RELAPSED CANCER
Clinical trials for RELAPSED CANCER explained in plain language.
Never miss a new study
Get alerted when new RELAPSED CANCER trials appear
Sign up with your email to follow new studies for RELAPSED CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a powerful myeloma drug move from hospital to home? study tests impact on families
Disease control Recruiting nowThis study aims to develop a safe process for giving the drug teclistamab to patients with advanced multiple myeloma in an outpatient or home setting, rather than requiring a hospital stay. It will enroll 15 patients who have tried at least three other treatments, along with thei…
Matched conditions: RELAPSED CANCER
Phase: PHASE4 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New Triple-Threat attack on tough brain cancer
Disease control Recruiting nowThis study is testing a combination of three drugs (pembrolizumab, ibrutinib, and rituximab) for adults with primary central nervous system lymphoma (PCNSL) that has returned or not responded to prior treatment. The goal is to see if this combination can control the cancer and st…
Matched conditions: RELAPSED CANCER
Phase: PHASE1, PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New hope for tough blood cancers: testing a powerful drug cocktail
Disease control Recruiting nowThis study is testing the safety and early effectiveness of a new drug, BGB-16673, when given with other cancer medicines. It is for people whose B-cell cancers, like certain lymphomas, have returned or stopped responding to previous treatments. The trial will test four different…
Matched conditions: RELAPSED CANCER
Phase: PHASE1, PHASE2 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New hope for Tough-to-Treat lymphoma: experimental combo aims to control disease
Disease control Recruiting nowThis study is testing whether adding a new drug called epcoritamab to a standard chemotherapy regimen (GDP) is safe and effective for adults whose large B-cell lymphoma has returned or stopped responding to prior treatment. The goal is to control the cancer and see if patients ca…
Matched conditions: RELAPSED CANCER
Phase: PHASE2 • Sponsor: Dipenkumar Modi • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New drug duo tested in fight against tough brain cancers
Disease control Recruiting nowThis study is testing whether combining two drugs, zanubrutinib and pemetrexed, can help control brain lymphomas that have come back or not responded to previous treatments. It will involve about 15 patients to first check safety and then see how well the treatment works to shrin…
Matched conditions: RELAPSED CANCER
Phase: PHASE2 • Sponsor: Baptist Health South Florida • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
New drug cocktail targets stubborn blood cancer
Disease control Recruiting nowThis study is testing a combination of four medications for people with multiple myeloma that has returned or stopped responding to prior treatments. The goal is to see how well this new combination controls the cancer and for how long. About 50 participants will receive the trea…
Matched conditions: RELAPSED CANCER
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
New hope for Tough-to-Treat blood cancer: trial tests Triple-Drug attack
Disease control Recruiting nowThis study is testing whether adding a new oral drug, roginolisib, to two standard drugs (venetoclax and rituximab) is safe and works better for people with chronic lymphocytic leukemia (CLL) that has come back or stopped responding to treatment. About 64 participants will receiv…
Matched conditions: RELAPSED CANCER
Phase: PHASE1, PHASE2 • Sponsor: Jennifer R. Brown, MD, PhD • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC